DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Jimenez-Yuste V. , Klamroth R, Castaman G, Ozelo M, Aout M, Meier O, Santagostino E.
A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of prophylactic emicizumab in persons with haemophilia A (PwHA) with FVIII inhibitors (STASEY): interim analysis results.
Oral Abstract OC 60.3.Paper presented at: International Society on Thrombosis and Haemostasis (ISTH) Congress, Melbourne, Australia, July 6–10, 2019. (Res PractThrombHemost2019;3(1))
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.